ANDREA STROTHER: Open Payments
NPI 1831719509 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 3 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
| ARGENX US, INC. | 1 | $16 |
Products named: Xeomin, HYQVIA, Symbravo, AMYVID, JOURNAVX, VYVGART HYTRULO.
Industry payments across LA — which companies pay providers there.
